Stentless Intravascular Lithotripsy (IVL) for the Paravisceral Coral Reef Aorta: A Case Report

Raoul Borioni1, Alessandra Rinaldi Garofalo1, Maria Chiara Tesori1

  • 1Vascular Surgery, Aurelia Hospital, Rome, ITA.

Cureus
|August 25, 2025
PubMed

Insights

Intravascular lithotripsy (IVL) offers a less invasive treatment for coral reef aorta (CRA), a condition causing leg pain due to aortic calcification. This technique effectively remodels calcified plaques, improving blood flow without stenting.

Area of Science:

  • Vascular Surgery
  • Interventional Cardiology
  • Medical Device Technology

Background:

  • Coral reef aorta (CRA) is a severe obstructive disease of the paravisceral abdominal aorta, marked by extensive calcification.
  • This calcification impairs visceral perfusion and causes exercise-limiting lower limb claudication, traditionally managed with open surgery.
  • Percutaneous endovascular techniques are emerging alternatives, but heavy calcifications pose a significant challenge.

Observation:

  • A case report details a 55-year-old female patient with bilateral exercise-limiting claudication due to paravisceral CRA.
  • The patient presented with no palpable femoral pulses, indicating severe arterial obstruction.
  • An endovascular approach was chosen for treatment.

Findings:

  • Intravascular lithotripsy (IVL) was employed without stenting via a percutaneous right femoral artery approach.
  • The IVL procedure resulted in significant plaque remodeling and improved arterial pressure in the distal aorta.
  • Post-procedure, the patient experienced no recurrence of claudication, with duplex ultrasound confirming restored triphasic arterial waveforms in the femoral arteries.

Implications:

  • IVL presents a promising, less invasive endovascular option for managing coral reef aorta, particularly in cases with significant calcifications.
  • Hemodynamic improvement can be achieved with IVL independently of stent placement.
  • Further clinical studies are necessary to establish the long-term efficacy and role of IVL in CRA treatment.